Wednesday, May 24 2017 - 9:30pm
Wednesday, May 24 2017 - 9:00pm
Wednesday, May 24 2017 - 1:00pm
Wednesday, May 24 2017 - 12:30pm
Wednesday, May 24 2017 - 12:00pm
$ORI said its BoD approved election of Dew, Dixon, and Van Mieghem as Class 2 directors for 3-year term. The Board considered result of shareholder proposal on proxy access in this year's Proxy Statement. At meeting the Board confirmed 3Q cash dividend of $0.1875 cents per share, payable on Sept. 15 to shareholders of record on Sept. 2.
For FY18, $MDT expects Cardiac & Vascular Group to grow in the range of 5-6%, Minimally Invasive Therapies Group to grow in the range of 3-4%, Restorative Therapies Group to grow approx. 4% and Diabetes to grow in the 10-12% range. Additionally, total $MDT revenue growth is expected to be similar to the annual range.
$SAFM expects production during 3Q17 and 4Q17 to be up 13.6% and 11.7%, compared to last year. The increase reflects new production at new St. Pauls, North Carolina, and Palestine, Texas, complexes as well as additional pounds it expects to process as result of its prior agreement with House of Raeford Farms.
During 1Q17, $DLTR Enterprise same-store sales rose 0.5%. Same-store sales for the Dollar Tree banner increased 2.5%, while that for the Family Dollar banner fell 1.2%. $DLTR opened 164 stores, expanded or relocated 51 stores, and closed 16 stores. Retail selling square footage at quarter-end was approximately 113.7MM square feet.
In 1Q18, $BBY achieved $50MM in annual cost reductions and gross profit optimization. The company has now reached its $400MM target three fiscal quarters ahead of its original deadline. $BBY is announcing a new target of $600MM in additional cost reduction and gross profit optimization to be completed by the end of FY21.